New test for bacteria in diabetic foot infections
Part of Heart & circulation, Hormones & metabolism, Infections, Skin clinical trials.
This trial tests a new portable device called MinION that can quickly identify bacteria in foot wounds of people with diabetic foot bone infections. It aims to help doctors choose the right antibiotic faster.
Summary written for real people, not researchers, by Clin2.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether smart insoles with real-time alerts, along with foot-care education, can help reduce foot problems in people with diabetes. You may benefit from better day-to-day foot monitoring and guidance to care for your feet safely.
This study looks at the bacteria in diabetic foot infections to better understand them. If you have a diabetic foot ulcer that is infected and haven't used antibiotics recently, you may be able to help by providing a small wound sample.
This study uses noninvasive (no major procedures) tests to better understand how diabetic foot ulcers or infections are healing. It may help doctors choose better ways to support wound healing in people with diabetes.
This trial is testing a new way to take a small sample of infected bone from the foot of people with diabetes. It aims to see if a bedside biopsy is safe and accurate for diagnosing bone infection, so you may avoid more invasive procedures.
This Phase 3 trial tests a new medicine (contezolid acefosamil, and contezolid) to treat moderate or severe diabetic foot infections. It compares the new treatment to linezolid to see which works better and is safer for adults.
This study tests a new device called Feetsee that helps monitor foot health in people with diabetes. It may help catch foot problems early.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.